↓ Skip to main content

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect…

Overview of attention for article published in CNS Drugs, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

policy
2 policy sources

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
74 Mendeley
Title
Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-Adjusted Indirect Comparison Methodology
Published in
CNS Drugs, August 2013
DOI 10.1007/s40263-013-0102-x
Pubmed ID
Authors

Vanja Sikirica, Robert L. Findling, James Signorovitch, M. Haim Erder, Ryan Dammerman, Paul Hodgkins, Mei Lu, Jipan Xie, Eric Q. Wu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
South Africa 1 1%
Brazil 1 1%
Unknown 71 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 19%
Researcher 10 14%
Student > Ph. D. Student 10 14%
Student > Bachelor 6 8%
Student > Doctoral Student 5 7%
Other 18 24%
Unknown 11 15%
Readers by discipline Count As %
Medicine and Dentistry 24 32%
Psychology 9 12%
Nursing and Health Professions 4 5%
Neuroscience 4 5%
Computer Science 3 4%
Other 13 18%
Unknown 17 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 September 2019.
All research outputs
#4,728,388
of 22,919,505 outputs
Outputs from CNS Drugs
#446
of 1,306 outputs
Outputs of similar age
#41,578
of 199,363 outputs
Outputs of similar age from CNS Drugs
#5
of 14 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,306 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,363 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.